Home
About Us
Issues
Authors
Reviewers
Users
Subscription
Our Other Journals
Site map
Aims and Scope
Salient Features
Editorial Board
Editorial Statements
Editorial-PeerReview Process
Publication Ethics & Malpractice
Publisher
Contact Us
Current Issue
Online Ahead of Print
Forthcoming
Article Archive
Access Statistics
Simple Search
Advanced Search
Submit an Article
Instructions
Assistance
Publication Fee
Paid Services
Apply As Reviewer
Acknowledgment
Register Here
Register For Article Submission
Login Here
Login For Article Submission
Annual
Buy One Issue
Payment Options
How to Order
JCDR
IJNMR
NJLM

 

Welcome : Guest

Users Online :

 

 

 

 

 

 

 

 

Original article / research

Year : 2024 Month : October-December Volume : 13 Issue : 6 Page : SO01 - SO04

Correlation of Calcium, Magnesium, Uric Acid and Phosphate Levels in Serum, 24-Hour Urine, and Stone Components in Patients with Urolithiasis: A Cross-sectional Study


Pranav Prakash, Shikhar Agarwal, Archana Prakash, Anita Sharma, Ashok Kumar Dogra, Sanjay Dvivedi
1. Postgraduate Student, Department of General Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India. 2. Professor, Department of Urology, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India. 3. Professor, Department of Biochemistry, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India. 4. Professor, Department of Biochemistry, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India. 5. Assistant Professor, Department of Biochemistry, Government Medical College, Srinagar, Jammu and Kashmir, India. 6. Professor, Department of General Surgery, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India.
 
Correspondence Address :
Dr. Ashok Kumar Dogra,
Assistant Professor, Department of Biochemistry, Government Medical College, Srinagar-190010, Jammu and Kashmir, India.
E-mail: akbhagat.pu@gmail.com
 
ABSTRACT

: Urolithiasis is the formation of stony concretions in the bladder or urinary tract. Nearly 10% of the population suffers from urolithiasis, which has a high chance of recurring. Many resources are used to treat urinary stones globally, but the need for prevention has been neglected.

Aim: To determine the levels of Calcium (Ca), Phosphorus (P), Uric Acid (UA) and Magnesium (Mg) in the blood and urine of patients with urolithiasis, as well as in urinary stones post-procedure.

Materials and Methods: This cross-sectional study was conducted at the Department of General Surgery at the Himalayan Institute of Medical Sciences (HIMS), Swami Ram Nagar, Dehradun, Uttarakhand, India, from November 2021 to October 2022. A total of 80 patients suffering from urolithiasis were involved in the study. Serum and 24-hour urinary samples were collected for quantitative analysis of Mg, Ca, UA and Phosphate (Ph) levels. Urinary stones postsurgery were sent to the biochemistry section of the reference laboratory for semi-quantitative colorimetric determination and morphological analysis. Spearman’s Rank correlation coefficient was used to correlate two quantitative variables and a p-value of <0.05 was considered statistically significant.

Results: In the study, 77.5% of the patients were males and 22.5% were females. Based on their fundamental components, a single calcium oxalate calculus was found in 39 patients. The levels of biochemical parameters associated with urinary stones were as follows: Ca component= 38.13±5.53 mg/dL; Mg component= 10.33±4.94 mg/dL; UA= 10.13±9.04 mg/dL; and Ph= 4.55±1.08 mg/dL. A strong positive correlation was observed between serum calcium and stone calcium (r=0.747, p=0.001) and between stone calcium and urine uric acid (r=0.813, p=0.001).

Conclusion: A significant relationship was observed between stone calcium and serum calcium.
Keywords : Calcium oxalate, Calculi, Renal, Urinary, Serum calcium
 
INTRODUCTION

Globally, urolithiasis is a complex clinical disorder that affects a significant number of people. Approximately 10% of individuals experience nephrolithiasis in their lifetimes and recurrence rates range from 50% to 70% in industrialised countries (1),(2). A 4:1 ratio of urinary calculi is seen in males compared to females and the condition is particularly prevalent in specific regions worldwide, such as Southern Asia (3),(4). A variety of modifiable dietary and lifestyle factors have been identified, such as a higher body mass index, lower fluid intake and the consumption of certain foods and beverages. Additionally, the risk of urolithiasis increases with decreased physical activity. The literature shows a consensus regarding diet and lifestyle, which has implications for patient advice (5). Researchers have found that calcium oxalate renal stones, the most commonly diagnosed type of stone, are primarily caused by diets high in protein, salt and fructose-containing beverages (6).

Often, urolithiasis is caused by supersaturated or stagnant urine. An evaluation of metabolic function is vital following the expulsion of stones and should be repeated several times. The treatment involves blood tests, urine samples and 24-hour urine collections to determine whether any crystallisation promoters or inhibitors are present. In addition, it is crucial to analyse the composition of the expelled stones (7),(8). Citric acid excretion through the urinary system is strongly associated with urinary stones. Accordingly, high urinary uric acid levels can lead to calcification, as can chronic dehydration and persistently low urinary Ph (9),(10).

As kidney stones become more prevalent in Indian populations, detailed characterisation is required (11),(12). Numerous studies have found that urinary calculi recur annually after previously treated patients experience their initial stone event. It appears that calculi should be prevented, rather than only treated, as it is a chronic disease (13),(14). The likelihood of developing urolithiasis increases when calcium, oxalate, uric acid and phosphorus are excreted in higher amounts in the urine. Therefore, it may be helpful to devise a treatment strategy based on the correlation between urine parameters in urolithiasis patients (15),(16),(17). A wide range of minerals can be found in urine and urine biomarkers are widely used for early disease diagnosis (18),(19),(20).

The study presented here evaluates the levels of calcium, phosphorus, uric acid and magnesium in serum, 24-hour urine and urinary stones in individuals suffering from urolithiasis. It also aimed to determine the correlation of these values in serum, 24-hour urine and urinary stones among patients with urolithiasis.
 
MATERIAL AND METHODS

The present cross-sectional study recruited 80 participants from the Department of General Surgery at the Himalayan Institute of Medical Sciences (HIMS), Swami Ram Nagar, Dehradun, Uttarakhand, India from November 2021 to October 2022. Informed consent was obtained from the patients and ethical clearance from the institute was granted with reference number SRHU/HIMS/ETHICS/2022/335. A consecutive sampling technique was employed.

Inclusion and Exclusion criteria: Patients of both genders over 18 years old, diagnosed with renal and/or ureteric stone disease, who were undergoing surgery for stone removal during the study period, were included. The exclusion criteria comprised individuals with infection stones (matrix), a history of recurrent Urinary Tract Infections (UTIs) in the last six months, malignancy, pregnancy, metabolic syndromes including hypertension, Type 2 diabetes and obesity, Pelvic Ureteric Junction (PUJ) obstruction, renal insufficiency, or any other related diseases.

Study Procedure

Diagnosed patients with urolithiasis were reviewed on an inpatient basis in the Urology/Surgery Department and were interviewed to gather their history and undergo examination for urinary stones. Their radiological findings were recorded on a case recording form. A consultant urologist performed the surgical removal of stones using ureteroscopic lithotripsy and Percutaneous Nephrolithotripsy (PCNL). According to the enrollment conditions, serum and 24-hour urinary samples were collected for quantitative analysis of magnesium, calcium, uric acid and phosphate levels and these were taken from patients after stone removal. The urinary stones, postsurgery, were sent to the reference laboratory in the Biochemistry section for semi-quantitative colorimetric determination conducted on an autoanalyser (Unicel DXC 700AU from Beckman Coulter) and for morphological analysis using a LIIR-20 automatic analyser (Lambda Science Corporation, China).

Statistical Analysis

Different statistical analyses were conducted using Statistical Package for the Social Sciences (SPSS) software version 22.0. Percentages and frequencies were calculated for all the considered variables. For quantitative variables, the authors provided the mean and standard deviation. The relationship between two quantitative variables was determined using Spearman’s Rank Correlation Coefficient. A p-value <0.05 was considered statistically significant, while a p-value >0.05 was considered not statistically significant.
 
RESULTS

In the study, 77.5% of the patients were males and 22.5% were females (Table/Fig 1). Based on their fundamental components, a single calcium oxalate calculus occurred in 39 patients. In the mixed calcium oxalate group, 25 patients had calcium oxalate and carbonate apatite stones, calcium oxalate and anhydrous uric acid stones, or calcium oxalate and magnesium ammonium phosphate stones (struvite). The other stone group included 16 patients with uric acid stones, apatites, sodium urates, or ammonium urates.

In 44 patients, the calyces and renal pelvis stones of the urinary tract were analysed by X-ray. The stones had diameters ranging from 7 to 18 mm. An X-ray diffraction analysis was used to define pure stones as those with more than 75% of their main component. Multiple stones were present in 67 (83.8%) of the urinary tracts assessed via NCCT. Smaller stones and those located further down the ureter are less likely to be identified by ultrasound.

The level of urinary calcium was found to be 3.43±0.97 (normal range: 2.5 to 7.5 mmoL/24 hrs) and the level of phosphate was 1.69±0.47 (normal range: 0.97 to 1.45 mmoL/24 hrs). The level of serum calcium was found to be 10.28±1.00 (normal range: 8.8 to 10.6 mg/dL) and the level of phosphate was 2.68±0.52 (normal range: 2.5 to 4.5 mg/dL) (Table/Fig 2).

The calcium component in urinary stones was measured at 38.13±5.53 (Table/Fig 3).

Correlation analysis revealed a strong positive correlation between serum calcium and stone calcium (r=0.747, p=0.001) (Table/Fig 4).

Additionally, there was a strong positive correlation between the amount of calcium in the stone and urinary Uric Acid (UA) (r=0.813, p=0.000) (Table/Fig 5).
 
DISCUSSION

Urinary stone disease is more common in men than in women. Statistically, the ratio of males to females in urolithiasis in Germany was found to be 1.4:1, as reported in an epidemiological study on urolithiasis in the country (21). The present study observed that 77.5% of the patients were males while 22.5% were females, showing a predominance of one sex over the other, which aligns with the epidemiological findings (22). According to the present study, the ratio of males to females was 3.4:1, which is consistent with the studies conducted by Sreenevasan G and Kant R et al., (23),(24).

In a related study, a reduction in crystal inhibitors or supersaturation of urine salts has been associated with an increased risk of stone formation (25). The prevalence of hyperoxaluria, hyperuricosuria, hypercalciuria and hypocitraturia was found to be higher in men, while urinary volume was lower in women, according to Yagisawa T et al., (26). In our study, serum and urinary calcium, urate, magnesium and phosphate levels were observed to be within normal limits in subjects with urolithiasis.

The present analysis revealed a strong correlation (r=0.747, p=0.0001) between the calcium component of the stone and serum calcium levels. Additionally, we noted a significant positive correlation between the amount of stone calcium and serum uric acid (r=0.634, p=0.0001). This finding is in line with previous studies that indicated the biochemical irregularities associated with uric acid stone formation are primarily due to decreased urine pH, followed by higher urinary urate levels and lower urine volume (27). Few studies have investigated the prophylactic effects of adequate fluid intake, even though urine volume is considered the most significant risk factor (6),(28).

An overabundance of uric acid crystals in the urine occurs when the urine pH drops below 5.5, a condition known as hypercalciuria. Stones can form when there is excessive uric acid in the urine. Individuals with high protein intake, particularly from red meat and poultry, are more likely to develop uric acid stones. It has been found that the case group, particularly male patients, had significantly higher serum uric acid levels (28). Some studies have documented and confirmed the role of urinary uric acid in the formation of calcium oxalate stones, highlighting the importance of treating hyperuricosuria (29),(30),(31). Therefore, a comprehensive understanding of the pathophysiology is essential when planning treatment. The present analysis revealed a comprehensive prediction of urolithiasis based on clinical factors and urinalysis, which may aid in patient-centred diagnostic imaging decisions.

Limitation(s)

The limitation of the present experiment was that the authors did not verify the consistency between morning urine and 24-hour urine by comparing and rectifying the urine chemical data. Moreover, the present study did not consider other parameters like urine Ph, specific gravity, or biochemical parameters that reflect protein and blood status.
 
CONCLUSION

A transparent relationship was observed between stone components and urinary and serum parameters. The most common type of stone was calcium oxalate. Moreover, a significant relationship was found between stone calcium and serum calcium, as well as between the amount of calcium in stones and urine UA in patients with urolithiasis. Hence, studies focussing on nutrition and metabolism are needed to determine modifiable factors that may facilitate better treatment planning from a clinical perspective.

Author’s contribution: Surgical and Medical Practices and Analysis or Interpretation: PP, Concept: SA, Design: AP, Data Collection or Processing: AS, Literature Search: SD, Writing: AKD.
 
REFERENCES
1.
Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al. Kidney stones. Nat Rev Dis Primers. 2016;2(1):16008.?doi?https://doi.org/10.1038/nrdp.2016.8#doi#?pmid?27188687#pmid#
2.
Kittanamongkolchai W, Vaughan LE, Enders FT, Dhondup T, Mehta RA, Krambeck AE, et al. The changing incidence and presentation of urinary stones over 3 decades. Mayo Clin Proc. 2018;93(3):291-99.?doi?https://doi.org/10.1016/j.mayocp.2017.11.018#doi#?pmid?29452705#pmid#
3.
Romero V, Akpinar H, Assimos DG. Kidney stones: A global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2-3):e86-96.
4.
Alelign T, Petros B. Kidney stone disease: An update on current concepts. Adv Urol. 2018;2018:3068365.?doi?https://doi.org/10.1155/2018/3068365#doi#?pmid?29515627#pmid#
5.
Boarin M, Villa G, Capuzzi C, Remon D, Abbadessa F, Manara DF. Dietary and lifestyle recommendations for urolithiasis prevention: A systematic literature review. Int J of Uro Nursing. 2018;12(2-3):53-70.?doi?https://doi.org/10.1111/ijun.12169#doi#
6.
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77-84.?doi?https://doi.org/10.1056/NEJMoa010369#doi#?pmid?11784873#pmid#
7.
Laube N, Pullmann M, Hergarten S, Hesse A. Influence of urinary stones on the composition of a 24-hour urine sample. Clin Chem. 2003;49(2):281-85.?doi?https://doi.org/10.1373/49.2.281#doi#?pmid?12560352#pmid#
8.
Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: A consensus statement. J Nephrol. 2016;29(6):715-34.?doi?https://doi.org/10.1007/s40620-016-0329-y#doi#?pmid?27456839#pmid#
9.
Dawson CH, Tomson CR. Kidney stone disease: Pathophysiology, investigation and medical treatment. Clinical Medicine. 2012;12(5):467-71.?doi?https://doi.org/10.7861/clinmedicine.12-5-467#doi#?pmid?23101150#pmid#
10.
Ogawa Y, Hatano T. Risk factors in urinary calcium oxalate stone formation and their relation to urinary calcium oxalate supersaturation. Int J of Urology. 1996;3(5):356-60.?doi?https://doi.org/10.1111/j.1442-2042.1996.tb00553.x#doi#?pmid?8886911#pmid#
11.
Onal EG, Tekgul H. Assessing kidney stone composition using smartphone microscopy and deep neural networks. BJUI Compass. 2022;3(4):310-15.?doi?https://doi.org/10.1002/bco2.137#doi#?pmid?35783589#pmid#
12.
Kumar V, Yadav AK, Sethi J, Ghosh A, Sahay M, Prasad N, et al. The Indian Chronic Kidney Disease (ICKD) study: Baseline characteristics. Clinical Kidney Journal. 2022;15(1):60-69.?doi?https://doi.org/10.1093/ckj/sfab149#doi#?pmid?35035937#pmid#
13.
Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, et al. Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158(7):535.?doi?https://doi.org/10.7326/0003-4819-158-7-201304020-00005#doi#?pmid?23546565#pmid#
14.
Sakhaee K, Maalouf NM, Sinnott B. Kidney stones 2012: Pathogenesis, diagnosis, and management. J Clin Endocrinol Metab. 2012;97(6):1847-60.?doi?https://doi.org/10.1210/jc.2011-3492#doi#?pmid?22466339#pmid#
15.
Tiselius H. Risk formulas in calcium oxalate urolithiasis. World J Urol. 1997;15(3):176-85.?doi?https://doi.org/10.1007/BF02201855#doi#?pmid?9228725#pmid#
16.
Wang P, Zhang H, Zhou J, Jin S, Liu C, Yang B, et al. Study of risk factor of urinary calculi according to the association between stone composition with urine component. Sci Rep. 2021;11(1):8723.?doi?https://doi.org/10.1038/s41598-021-87733-7#doi#?pmid?33888737#pmid#
17.
Otnes B. Urinary stone analysis methods, materials and value. Scand J Urol Nephrol Suppl. 1983;71:01-109.
18.
Washino S, Hosohata K, Miyagawa T. Roles played by biomarkers of kidney injury in patients with upper urinary tract obstruction. IJMS. 2020;21(15):5490.?doi?https://doi.org/10.3390/ijms21155490#doi#?pmid?32752030#pmid#
19.
Williams JC, Gambaro G, Rodgers A, Asplin J, Bonny O, Costa-Bauzá A, et al. Urine and stone analysis for the investigation of the renal stone former: A consensus conference. Urolithiasis. 2021;49(1):1-16.?doi?https://doi.org/10.1007/s00240-020-01217-3#doi#?pmid?33048172#pmid#
20.
Liu Y, Chen Y, Liao B, Luo D, Wang K, Li H, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018;5(4):205-14.?doi?https://doi.org/10.1016/j.ajur.2018.08.007#doi#?pmid?30364478#pmid#
21.
Healy KA, Hubosky SG, Bagley DH. 24-Hour urine collection in the metabolic evaluation of stone formers: Is one study adequate? J Endourol. 2013;27(3):374-78.?doi?https://doi.org/10.1089/end.2012.0216#doi#?pmid?22967013#pmid#
22.
Roger C, Abid N, Dubourg L, Auvergnon C, Lemoine S, Machon C. Composition of urinary calculi: Lessons from a French epidemiologic retrospective study. Prog Urol. 2020;30(6):339-45.?doi?https://doi.org/10.1016/j.purol.2020.03.003#doi#?pmid?32312624#pmid#
23.
Sreenevasan G. Incidence of urinary stones in the various states of mainland Malaysia. Med J Malaysia. 1981;36(3):142-47.
24.
Kant R, Singh TG, Singh S. Mechanistic approach to herbal formulations used for urolithiasis treatment. Obesity Medicine. 2020;19:100266.?doi?https://doi.org/10.1016/j.obmed.2020.100266#doi#
25.
Tefekli A, Cezayirli F. The history of urinary stones: In parallel with civilization. The Scientific World Journal. 2013;2013(1):423964.?doi?https://doi.org/10.1155/2013/423964#doi#?pmid?24348156#pmid#
26.
Yagisawa T, Chandhoke PS, Fan J. Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation. Urology. 1998;52(5):750-55.?doi?https://doi.org/10.1016/S0090-4295(98)00340-9#doi#?pmid?9801093#pmid#
27.
Negri AL, Spivacow R, Del Valle E, Pinduli I, Marino A, Fradinger E, et al. Clinical and biochemical profile of patients with “pure” uric acid nephrolithiasis compared with “pure” calcium oxalate stone formers. Urol Res. 2007;35(5):247-51.?doi?https://doi.org/10.1007/s00240-007-0109-1#doi#?pmid?17786420#pmid#
28.
Bao Y, Tu X, Wei Q. Water for preventing urinary stones. Cochrane Database Syst Rev. 2020;2020(3):CD004292.?doi?https://doi.org/10.1002/14651858.CD004292.pub4#doi#?pmid?32045491#pmid#
29.
KC M, Leslie SW. Uric Acid Nephrolithiasis. [Updated 2023 Oct 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560726/.
30.
Daudon M, Jungers P, Bazin D, Williams JC. Jr. Recurrence rates of urinary calculi according to stone composition and morphology. Urolithiasis. 2018;46:459-70. ?doi?https://doi.org/10.1007/s00240-018-1043-0#doi#?pmid?29392338#pmid#
31.
Samuell CT, Kasidas GP. Biochemical Investigations in Renal Stone Formers. Ann Clin Biochem. 1995;32(2):112-22.?doi?https://doi.org/10.1177/000456329503200202#doi#?pmid?7785940#pmid#
 
TABLES AND FIGURES
[Table / Fig - 1]  [Table / Fig - 2]  [Table / Fig - 3]  [Table / Fig - 4]  [Table / Fig - 5]
 
 
 

In This Article

  • Abstract
  • Material and Methods
  • Results
  • Discussion
  • Conclusion
  • References

Article Utilities

  • Readers Comments
  • Article in PDF
  • Citation Manager
  • How to Cite
  • Article Statistics
  • Link to PUBMED
  • Print this Article
  • Send to a Friend

Quick Links

REVIEWER
ACCESS STATISTICS
Home  |  About Us  |  Online First  |  Current Issue  |  Simple Search  |  Advance Search  |  Register  |  Login  |  Contact  |  Privacy Policy  |  Terms of Use
Author Support  |  Submit Manuscript  |  IJARS Pre-Publishing  |  Reviewer  |  Articles Archive  |  Access Statistics
© 2025 INTERNATIONAL JOURNAL OF ANATOMY RADIOLOGY & SURGERY (IJARS), ISSN : 2277-8543.
EDITORIAL OFFICE : 1/9, Roop Nagar, Delhi 11000. Phone : 01123848553

* This Journal is owned and run by medical professionals *